학술논문
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?
Document Type
Article
Author
Source
In: Leukemia . (Leukemia, May 2024, 38(5):947-950)
Subject
Language
English
ISSN
14765551
08876924
08876924